BMEA Stock Analysis: Buy, Sell, or Hold?
BMEA - Biomea Fusion, Inc. Common Stock
$1.27
-0.10 (-7.30%)
▼
5d:
-7.97%
30d:
-20.63%
90d:
-8.63%
HOLD
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When BMEA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BMEA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BMEA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BMEA is currently trading at $1.27, which is considered oversold relative to its 30-day fair value range of $1.31 to $1.55.
Technical Outlook: Technically, BMEA is in a downtrend. The price is currently testing key support at $1.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.83 (+438.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BMEA is in a downtrend. The price is currently testing key support at $1.26. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.83 (+438.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.31 -
$1.55
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.3%)
- BULLISH: Trading 438.1% below Wall St target ($6.83)
- CAUTION: Recommendation downgraded due to -8.0% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.31 -
$1.55
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.27
Resistance Level
$1.48
Current Trend
Downtrend
Technical data as of
Jun 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.15
Wall Street Target
$6.83
(+438.1%)
Share & Embed Analysis
Last updated: June 06, 2026 5:28 AM ET
Data refreshes hourly during market hours. Next update: 6:28 AM
Data refreshes hourly during market hours. Next update: 6:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BMEA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Rainer M Erdtmann
BUY
30000 shares
2025-12-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 64 BUY |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 53 HOLD |
